Drug Discovery and Development: Senators Booker and Paul Aim to Reschedule Psilocybin and MDMA to Foster Research

Summary: U.S. Senators Cory Booker (D-N.J.) and Rand Paul (R-KY) have drafted the Breakthrough Therapies Act, which would enable the Drug Enforcement Agency (DEA) to research rescheduling Schedule I drugs such as psilocybin and MDMA to Schedule II.

Originally appearing here (Archived)